Data as of Sep 16
| -0.09 / -7.50%|
The 2 analysts offering 12-month price forecasts for Aveo Pharmaceuticals Inc have a median target of 1.50, with a high estimate of 2.00 and a low estimate of 1.00. The median estimate represents a +35.14% increase from the last price of 1.11.
The current consensus among 3 polled investment analysts is to Sell stock in Aveo Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.